<< Read Full Article
<< Read Full Article
ImClone Systems CEO Steps Down
Updated from 5:14 p.m. EDT
ImClone Systems (IMCL Quote) said late Wednesday that CEO Sam Waksal has resigned from the troubled biotech company.
Waksal is stepping down to shield the company from his personal troubles, which include investigations into his sales of ImClone stock before the company's experimental cancer drug, Erbitux, ran into troubles with U.S. drug regulators.
Waksal's brother, Harlan Waksal, the company's current COO, has been named the new president and CEO. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,285.97 | 1,091.93 | 2,172.99 | 33.92 |
Oil *
75.40
|
|
DOWN
104.14
|
DOWN
11.32
|
DOWN
16.62
|
DOWN
0.56
|
10 Yr
3.39%
SPDR Gold
110.95
|
|
-1.00%
|
-1.03%
|
-0.76%
|
-1.62%
|
Data delayed 20 minutes |
Connect with TheStreet